` HSCS (Heart Test Laboratories Inc) vs S&P 500 Comparison - Alpha Spread

HSCS
vs
S&P 500

Over the past 12 months, HSCS has underperformed S&P 500, delivering a return of -34% compared to the S&P 500's +12% growth.

Stocks Performance
HSCS vs S&P 500

Loading
HSCS
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HSCS vs S&P 500

Performance Gap Between HSCS and GSPC
HIDDEN
Show

Performance By Year
HSCS vs S&P 500

Loading
HSCS
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Heart Test Laboratories Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Heart Test Laboratories Inc
Glance View

Market Cap
6.8m USD
Industry
Health Care

Heart Test Laboratories Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Southlake, Texas and currently employs 12 full-time employees. The company went IPO on 2022-06-15. Heart Test Laboratories, Inc. is a medical technology company focused on developing artificial intelligence (AI) based technology to an electrocardiogram (ECG) to expand and improve an ECG’s clinical usefulness. The Company’s product candidate, the MyoVista wavECG, or the MyoVista, is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista is a 12-lead resting ECG device that features its algorithm developed to detect cardiac dysfunction in the diastolic phase, specifically slower than normal left ventricular relaxation rates. The MyoVista uses electrical information from the heart captured during a standard resting 12-lead ECG test as inputs to an artificial intelligence-based algorithm. The MyoVista detects whether a patient is negative or positive for abnormally slow left ventricular diastolic relaxation rates.

HSCS Intrinsic Value
HIDDEN
Show
Back to Top